Karyopharm Therapeutics KPTI
$ 0.77
-0.66%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 05.11.2024
Karyopharm Therapeutics Мультипликаторы 2011-2024 | KPTI
Мультипликаторы по годам Karyopharm Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.9 | -1.8 | -5.4 | -5.6 | -5.0 | -2.7 | -4.3 | -3.5 | -1.9 | -10.9 | -5.9 | - | - |
P/S |
0.9 | 1.9 | 3.2 | 10.2 | 24.5 | 16.0 | 342.9 | 2504.8 | 886.2 | 3607.1 | 518.2 | - | - |
EPS |
-1.2 | -2.0 | -1.6 | -2.7 | -3.2 | -3.1 | -2.8 | -2.9 | -3.3 | -2.4 | -5.6 | -8.9 | -10.3 |
EV (Enterprise Value) |
455 млн | 533 млн | 864 млн | 1.27 млрд | 1.12 млрд | 526 млн | 532 млн | 354 млн | 180 млн | 689 млн | 47.9 млн | 28.8 млн | 13.4 млн |
EBITDA per Share |
-1.13 | -1.73 | -1.3 | -2.37 | -3.04 | -3.15 | -2.83 | -2.93 | -3.33 | -2.43 | -5.57 | - | - |
EV/EBITDA |
-8.2 | -6.7 | -5.2 | -2.6 | -3.7 | -3.1 | -1.4 | -8.9 | -1.3 | - | - | ||
PEG |
0.06 | 0.34 | 0.43 | 0.95 | -1.97 | -0.23 | 1.13 | 0.29 | -0.05 | 0.19 | -0.06 | - | - |
P/B |
-1.0 | -17.6 | -8.4 | 21.7 | 20.1 | 2.7 | 4.3 | 2.4 | 1.1 | 4.0 | 1.3 | - | - |
P/CF |
-1.4 | -2.0 | -6.2 | -6.8 | -5.2 | -3.0 | -7.5 | -4.6 | -2.3 | -15.2 | -6.6 | - | - |
ROE % |
105.06 | 992.38 | 155.75 | -388.31 | -400.99 | -97.40 | -99.63 | -67.54 | -59.58 | -36.64 | -21.91 | - | - |
ROA % |
-59.52 | -46.15 | -40.64 | -62.70 | -67.67 | -52.29 | -71.54 | -60.75 | -54.85 | -34.39 | -21.45 | - | - |
ROCE % |
95.11 | 853.76 | 123.34 | -339.99 | -76.13 | -61.12 | -99.78 | -67.56 | -59.45 | -36.46 | -21.91 | - | - |
Current Ratio |
0.6 | 1.0 | 0.8 | 1.2 | 6.0 | 7.1 | 3.0 | 8.0 | 11.7 | 16.9 | 48.0 | - | - |
DSO |
92.5 | 80.8 | 30.8 | 35.0 | 70.2 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | 52.5 | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | 149.4 | - | - | - | - | - | - | - | - |
Операционный цикл |
92.5 | 80.8 | 30.8 | 35.0 | 122.6 | - | - | - | - | - | - | - | - |
Финансовый цикл |
92.5 | 80.8 | 30.8 | 35.0 | -26.7 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Karyopharm Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.26 | 0.15 | -0.32 | - | -0.3 | -0.29 | -0.3 | - | -0.45 | -0.62 | -0.53 | - | -0.69 | -0.71 | -0.77 | - | -0.73 | -0.63 | -0.78 | - | -0.67 | -0.71 | -1.09 | -0.96 | -0.79 | -0.6 | -0.78 | -0.8 | -0.65 | -0.64 | -0.71 | -0.65 | -0.69 | -0.84 | -0.75 | -0.81 | -0.85 | -0.92 | -0.74 | -0.79 | -0.61 | -0.55 | -0.46 | -0.72 | -3.66 | -2.86 | -2.52 | -2.08 | -1.97 | -2.37 | -2.71 | - | - | - | - |
EBITDA per Share |
- | - | -0.29 | - | - | - | -0.27 | - | -0.38 | -0.54 | -0.44 | - | -0.57 | -0.65 | -0.7 | - | -0.63 | -0.54 | -697 | - | -623 | -676 | -1.06 тыс. | -0.94 | -0.8 | -0.61 | -0.78 | -0.8 | -0.65 | -0.64 | -0.72 | -0.65 | -0.68 | -0.84 | -0.76 | -0.82 | -0.84 | -0.92 | -0.74 | -0.79 | -0.6 | -0.55 | -0.46 | -0.41 | -3.62 | -2.83 | -2.51 | -2 | 1.8 млн | - | - | - | - | - | - |
ROE % |
58.57 | 72.85 | 136.65 | 155.71 | 181.61 | 173.13 | 169.50 | 117.90 | 159.02 | 174.26 | 196.54 | 250.42 | 144.59 | -2.38 | -158.68 | -302.40 | -385.51 | -362.79 | -358.16 | -303.26 | -335.04 | -278.18 | -209.33 | -97.40 | -95.78 | -93.19 | -97.52 | -99.63 | -86.08 | -78.08 | -73.97 | -67.54 | -65.58 | -65.22 | -63.11 | -59.58 | -57.47 | -51.70 | -43.16 | -36.64 | -31.95 | -28.42 | -24.91 | -21.91 | 1.13 | 20.19 | 24.62 | 28.24 | 13.04 | - | - | - | - | - | - |
ROA % |
-36.86 | -32.72 | -54.79 | -34.21 | -49.92 | -52.85 | -55.97 | -43.87 | -64.26 | -54.86 | -73.56 | -59.97 | -77.06 | -73.76 | -69.89 | -48.83 | -62.85 | -59.79 | -59.68 | -51.17 | -68.23 | -68.30 | -63.45 | -52.29 | -56.88 | -59.78 | -66.22 | -71.54 | -64.82 | -61.92 | -62.34 | -60.75 | -59.30 | -59.30 | -57.76 | -54.85 | -53.14 | -47.99 | -40.28 | -34.39 | -30.30 | -27.24 | -24.12 | -21.45 | -337.04 | -608.42 | -604.08 | -600.53 | -277.27 | - | - | - | - | - | - |
ROCE % |
88.86 | 103.53 | 123.76 | 141.04 | 163.03 | 153.87 | 149.25 | 100.50 | 135.27 | 148.07 | 170.19 | 225.90 | 132.70 | 4.72 | -134.05 | -266.66 | -345.82 | -331.78 | -335.76 | -293.34 | -324.71 | -272.39 | -207.38 | -98.21 | -97.31 | -94.46 | -98.70 | -100.83 | -87.10 | -78.98 | -74.78 | -68.25 | -66.28 | -65.84 | -63.70 | -60.03 | -57.80 | -51.92 | -43.23 | -36.68 | -31.97 | -28.44 | -24.92 | -21.91 | 1.13 | 20.19 | 24.62 | 28.24 | 13.04 | - | - | - | - | - | - |
Current Ratio |
0.5 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.9 | 1.0 | 0.6 | - | 0.8 | 0.8 | 0.7 | 0.8 | 0.9 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 2.2 | 2.2 | 2.2 | 2.2 | 3.5 | 3.5 | 3.5 | 3.5 | 9.9 | 9.9 | 9.9 | 9.9 | 12.6 | 12.6 | 12.6 | 12.6 | 16.3 | 16.3 | 16.3 | 16.3 | 48.1 | 48.1 | 48.1 | - | - | - | - | - | - | - | - | - |
DSO |
82.1 | 73.7 | 79.9 | - | 89.0 | 81.9 | 97.0 | - | 34.6 | 28.7 | 45.5 | - | 44.4 | 72.1 | 60.3 | - | 55.1 | 35.1 | 52.2 | - | 54.6 | 75.6 | 2314.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 88.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
82.1 | 73.7 | 79.9 | - | 89.0 | 81.9 | 97.0 | - | 34.6 | 28.7 | 45.5 | - | 44.4 | 72.1 | 60.3 | - | 55.1 | 35.1 | 52.2 | - | 85.7 | 75.6 | 2314.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
82.1 | 73.7 | 79.9 | - | 89.0 | 81.9 | 97.0 | - | 34.6 | 28.7 | 45.5 | - | 44.4 | 72.1 | 60.3 | - | 55.1 | 35.1 | 52.2 | - | -3.0 | 75.6 | 2314.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD